Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Burkitt Lymphoma × Immunoconjugates × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Recurrence 3 Rectal Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Stomach Neoplasms 1 Prostatic Neoplasms 1 Multiple Myeloma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell 1 Lymphoma 1 Colonic Neoplasms 1 Burkitt Lymphoma 1 Brain Neoplasms 1 Alopecia 1

Interventions

Cyclophosphamide 190 Rituximab 94 Etoposide 89 Filgrastim 82 Vincristine 77 Cytarabine 77 Peripheral Blood Stem Cell Transplantation 75 Methotrexate 74 fludarabine phosphate 69 Radiotherapy 59 Prednisone 59 Doxorubicin 58 Whole-Body Irradiation 46 Cyclosporine 45 Dexamethasone 44 Mycophenolic Acid 43 Melphalan 38 Busulfan 38 fludarabine 37 Tacrolimus 34 Methylprednisolone 34 Antilymphocyte Serum 33 merphos 30 blinatumomab 30 Granulocyte Colony-Stimulating Factor 27 Leucovorin 26 Calcium Dobesilate 26 deltacortene 23 Carmustine 23 prednylidene 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06796517 2025-01-28

Immunotherapy in Lymphoma

Seoul St. Mary's Hospital

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡